<SEC-DOCUMENT>0001615774-15-001396.txt : 20150608
<SEC-HEADER>0001615774-15-001396.hdr.sgml : 20150608
<ACCEPTANCE-DATETIME>20150608111445
ACCESSION NUMBER:		0001615774-15-001396
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20150430
FILED AS OF DATE:		20150608
DATE AS OF CHANGE:		20150608

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DanDrit Biotech USA, Inc.
		CENTRAL INDEX KEY:			0001527728
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				452259340
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		DANDRIT BIOTECH A/S
		STREET 2:		FRUEBJERGVEJ 3 BOX 62
		CITY:			2100 COPENHAGEN
		STATE:			G7
		ZIP:			0
		BUSINESS PHONE:		45 39179840

	MAIL ADDRESS:	
		STREET 1:		DANDRIT BIOTECH A/S
		STREET 2:		FRUEBJERGVEJ 3 BOX 62
		CITY:			2100 COPENHAGEN
		STATE:			G7
		ZIP:			0

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Putnam Hills Corp.
		DATE OF NAME CHANGE:	20110810

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Degn Lone
		CENTRAL INDEX KEY:			0001643314

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-54478
		FILM NUMBER:		15917763

	MAIL ADDRESS:	
		STREET 1:		FRUEBJERGVEJ 3 BOX 62
		CITY:			COPENHAGEN
		STATE:			G7
		ZIP:			2100

	FORMER NAME:	
		FORMER CONFORMED NAME:	Lone Degn
		DATE OF NAME CHANGE:	20150526
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>s101143_form3.xml
<DESCRIPTION>3
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0206</schemaVersion>

    <documentType>3</documentType>

    <periodOfReport>2015-04-30</periodOfReport>

    <noSecuritiesOwned>1</noSecuritiesOwned>

    <issuer>
        <issuerCik>0001527728</issuerCik>
        <issuerName>DanDrit Biotech USA, Inc.</issuerName>
        <issuerTradingSymbol>DDRT</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001643314</rptOwnerCik>
            <rptOwnerName>Degn Lone</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>FRUEBJERGVEJ 3 BOX 62</rptOwnerStreet1>
            <rptOwnerStreet2></rptOwnerStreet2>
            <rptOwnerCity>COPENHAGEN</rptOwnerCity>
            <rptOwnerState>G7</rptOwnerState>
            <rptOwnerZipCode>2100</rptOwnerZipCode>
            <rptOwnerStateDescription>DENMARK</rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>1</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle>Chief Financial Officer (1)</officerTitle>
            <otherText></otherText>
        </reportingOwnerRelationship>
    </reportingOwner>

    <remarks>(1) Effective April 30, 2015, the Board of Directors of DanDrit Biotech USAS, Inc. appointed Lone Degn to serve in the office of Chief Financial Officer until her successor is duly elected, qualified and seated or until her earlier resignation or removal.</remarks>

    <ownerSignature>
        <signatureName>/s/ Lone Degn</signatureName>
        <signatureDate>2015-05-26</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
